NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST – A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Pharmateca ◽  
2018 ◽  
Vol 4_2018 ◽  
pp. 9-15
Author(s):  
T.Yu. Demidova Demidova ◽  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Agonist

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

2020 ◽  
Author(s):  
Jersy Cardenas ◽  
Gomez Nancy Sanchez ◽  
Sierra Poyatos Roberto Miguel ◽  
Luca Bogdana Luiza ◽  
Mostoles Naiara Modroño ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonist ◽  
Obese Patients ◽  
Real World Data ◽  
World Data

scholarly journals LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept

2018 ◽  
Vol 18 ◽  
pp. 3-14 ◽  
Author(s):  
Tamer Coskun ◽  
Kyle W. Sloop ◽  
Corina Loghin ◽  
Jorge Alsina-Fernandez ◽  
Shweta Urva ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Receptor Agonist ◽  
Proof Of Concept

scholarly journals Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

2019 ◽  
Vol 10 (2) ◽  
pp. 735-749 ◽  
Author(s):  
Anne Brooks ◽  
Jakob Langer ◽  
Tommi Tervonen ◽  
Mads Peter Hemmingsen ◽  
Kosei Eguchi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Discrete Choice Experiment ◽  
Discrete Choice ◽  
Patient Preferences ◽  
Choice Experiment ◽  
Receptor Agonist
Sign in / Sign up

Export Citation Format

Share Document